Neurocrine Biosciences is a biopharmaceutical company based in San Diego, California, that discovers and develops medicines for neurological, psychiatric and endocrine conditions. Its products treat movement disorders such as tardive dyskinesia and Huntington's disease chorea, and it also offers treatments for endometriosis-related pain. The company serves patients and healthcare providers, mainly through specialty pharmacies and physicians in the United States, and it conducts research on disorders of the nervous and hormonal systems.
Neurocrine Biosciences Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code N1BI34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #806 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
44/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-5.8%
From 52-week high-21.9%
MomentumWeak
44/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-16.6%
6-month return8.7%
12-month, skipping last month2.0%
Stability (higher is calmer)Fair
66/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)32.3%
Worst drawdown, 1 year (smaller is calmer)-25.1%
LiquidityWeak
37/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.05M BRL
Zero-volume days46.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 31.51 – 45.78Daily closes, split-adjusted
Signals
50-day average38.48
200-day average37.98
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.51
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
35.58
Bullish
EMA 10
35.61
Bullish
SMA 20
36.06
Bearish
EMA 20
36.29
Bearish
SMA 50
38.48
Bearish
EMA 50
38.03
Bearish
SMA 100
40.68
Bearish
EMA 100
38.86
Bearish
SMA 200
37.98
Bearish
EMA 200
38.58
Bearish
Oscillators (daily)
RSI (14)
39.33
Neutral
MACD (12, 26)
-0.98
Bearish
Momentum (12)
-3.46
Bearish
Stochastic %K (14)
46.36
Neutral
Williams %R (14)
-53.64
Neutral
CCI (20)
-79.76
Neutral
Pivot points (classic, last session)
S3
33.76
S2
34.16
S1
34.96
Pivot
35.36
R1
36.16
R2
36.56
R3
37.36
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
